The emerging therapy of the medication represents a major development in the handling of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide affects multiple pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide209508.blogpixi.com/42423568/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment